Brilliant Violet 421™ anti-mouse CD41

Antibodies Single
Sony
MWReg30
Flow Cytometry
Rat IgG1, κ
Mouse
Mouse platelets
1269560
$290.00

Description

CD41, also known as integrin α2b and GPIIb, is a transmembrane glycoprotein that is expressed by platelets and megakaryocytes. It was reported that CD41 is also expressed on hematopoietic progenitors. CD41 associates with CD61 (integrin β3) to form complexes that interact with fibrinogen, fibronectin, von Willebrand factor, and thrombin. CD41 is required for platelet adhesion and aggregation. Defect of CD41 leads to disorders of coagulation.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Nieswandt B, et al. 1999. Blood 94:684.
2. Teeling JL, et al. 2001. Blood 98:1095.
3. Bertrand JY, et al. 2005. P. Natl. Acad. Sci. USA 102:134.
4. Nocito A, et al. 2007. Hepatology 45:369. (Deplete)
5. Sullivan BP, et al. 2010. Toxicol. Sci. 115:286. (Deplete) PubMed
6. van der Heyde HC, et al. 2005. Blood 105:1956. (FA)
7. Marjon KD, et al. 2009. J. Immunol. 182:1397. (Deplete)
8. Rao TN, et al. 2015. Stem Cell Res.14:307. PubMed
9. Marks-Bluth J, et al. 2015. Mol Cell Biol. 35:2165. PubMed